Merck & Co. released their drug pricing information late last week. The data includes drug pricing increases and basic breakdowns of drug costs over the years. Also included in the information was the average discounted rate at which Merck & Co. drugs are sold to consumers. This release came just days before Donald Trump’s meeting with pharmaceutical executives about drug pricing. Merck is one of many companies that has taken steps to increase market transparency through “report card” pricing information in the past few months. Read the full article, here.